跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
鍾 明怡
副教授
生命科學系暨基因體科學研究所
電話
02-2871-2121#3265
電子郵件
mychung
nycu.edu
tw
h-index
h10-index
h5-index
4560
引文
30
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
396
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
18
引文
2
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1991 …
2023
每年研究成果
概覽
指紋
網路
研究成果
(62)
類似的個人檔案
(6)
指紋
查看啟用 Ming-Yi Chung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
22q11.2 Microdeletion
35%
Age of Onset
13%
Areca
12%
Arteriovenous Fistula
49%
Asthma
17%
Asymmetric Dimethylarginine
49%
Attention Deficit Hyperactivity Disorder
35%
Bipolar Disorder
12%
CAG Repeat
13%
Chromosome 22
17%
Chromosome 22q11.2
29%
Clinical Outcomes
17%
Conotruncal Defects
11%
Dimethylarginine Dimethylaminohydrolase
17%
Fistula Patency
27%
Gene Polymorphism
37%
Genetic Polymorphism
22%
Genotype
63%
Genotype Polymorphism
12%
Heme oxygenase-1 (HO-1)
28%
Heme oxygenase-1 Gene
12%
Hemodialysis Patients
53%
Interleukin-4 (IL-4)
17%
Length Polymorphism
19%
Loss of Heterozygosity
16%
Major Adverse Cardiovascular Events
17%
Matrix metalloproteinase-1 (MMP-1)
17%
Microdeletion
19%
Microsatellite Alterations
17%
Migraine
19%
Molecular Characterization
21%
Mutation Analysis
14%
Odds Ratio
23%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
35%
Parent-of-origin
20%
Peripheral Blood Cells
13%
Peripheral Blood Mononuclear Cells
16%
Polymorphism
30%
Potential Biomarkers
19%
Prostate Cancer
17%
Repeat Polymorphism
13%
Restless Legs Syndrome
17%
Single nucleotide Polymorphism
18%
Spinocerebellar Ataxia
71%
Susceptibility Genes
24%
Taiwan
24%
Taiwanese
31%
Taiwanese children
17%
Tetralogy of Fallot
35%
Trinucleotide
17%
Biochemistry, Genetics and Molecular Biology
Allele
56%
Areca
12%
Autosomal Dominant Inheritance
31%
Blood Plasma
40%
CAG Repeat
22%
Candidate Gene
11%
Case-Control Study
11%
Chromosome 22
35%
Coding Region
13%
Cohort Study
10%
Contig
13%
Dimethylargininase
17%
Dopamine Receptor D4
9%
Enzyme
9%
Exon
28%
Gene Polymorphism
29%
Gene Promoter
13%
Genetic Polymorphism
14%
Genetics
20%
Genome Wide Association Study
10%
Genome-Wide Association Study
17%
Genomics
10%
Genotyping
100%
Haplotype
18%
Heme Oxygenase
35%
Hemizygosity
13%
Hemodialysis
35%
Human Chromosome
10%
Immunoglobulin E
10%
Interleukin 4
17%
Loss of Heterozygosity
18%
Messenger RNA
34%
Microsatellite
37%
Microsatellite Instability
9%
Microsatellite Marker
11%
Missense Mutation
11%
Nitric Oxide
11%
Patency
20%
Peripheral Blood Cell
13%
Peripheral Blood Mononuclear Cell
14%
Prevalence
9%
Promoter Region
45%
Protein Sequencing
11%
Real-Time Polymerase Chain Reaction
28%
S100A10
8%
Shotgun Sequencing
11%
Single-Nucleotide Polymorphism
23%
Trinucleotide Repeat Expansion
11%
Untranslated Region
10%
Zebra Fish
11%
Medicine and Dentistry
Angiomyolipoma
8%
Attention Deficit Disorder
26%
Birth Outcomes
8%
Carcinogenesis
8%
Cardiovascular Disease
16%
Cardiovascular System
11%
Case-Control Study
8%
Chromosome 16p
8%
Chronic Kidney Disease
8%
Cohort Analysis
8%
Colorectal Carcinoma
8%
Congestive Heart Failure
8%
Coronary Angiography
9%
Dimethylargininase
8%
Endometrial Stromal Sarcoma
8%
Esophageal Squamous Cell Carcinoma
8%
Fetus Development
10%
Gelatinase A
8%
Glycemic Control
8%
Haplotype
8%
Heme Oxygenase 1
8%
Hemodialysis
8%
Heterozygosity
15%
Interstitial Collagenase
8%
Intimal Hyperplasia
8%
Laparoscopic Surgery
8%
Methyltransferase
8%
Migraine
8%
Mitochondrial DNA
8%
Mouth Squamous Cell Carcinoma
26%
N(g),n(g) Dimethylarginine
43%
Neoplasm
14%
Nonylphenol
8%
Odds Ratio
9%
Oral Submucous Fibrosis
12%
Organophosphate Pesticide
8%
Patient with Type 2 Diabetes
8%
Perivascular Epithelioid Cell Tumour
8%
Prevalence
8%
Promoter Region
28%
Prostate Cancer
8%
Protein Degradation
8%
Restenosis
7%
Restless Legs Syndrome
8%
Single Nucleotide Polymorphism
6%
Squamous Cell Carcinoma
11%
Tetralogy of Fallot
26%
Tumor Cell
8%
Ubiquitin
8%
Urinary System
19%
